© Copyright 2025 American Medical Association. All rights reserved.
The CPT® Code 90674 refers to a specific formulation of the influenza virus vaccine known as the quadrivalent cell culture-derived inactivated influenza vaccine (ccIIV4). This vaccine is designed to provide active, long-term immunity against influenza by stimulating the recipient's immune system to produce antibodies. Unlike immune globulins, which offer short-term, passive immunity, vaccines like this one expose the immune system to altered versions of the influenza virus, prompting it to recognize and combat the virus upon future exposure. The unique aspect of this vaccine is that it is derived from cell cultures, which allows for production in a sterile and controlled environment, eliminating the need for embryonated eggs, preservatives, and antibiotics. This makes the vaccine non-allergenic and suitable for individuals who may have sensitivities to these components. The quadrivalent formulation includes two strains of influenza type A and two strains of influenza type B, providing broader protection against circulating influenza viruses. The specific dosage for this vaccine is 0.5 mL, and it is intended for intramuscular administration. The code 90674 is used solely to report the vaccine product itself, ensuring accurate documentation and billing for the immunization provided.
© Copyright 2025 Coding Ahead. All rights reserved.
The influenza virus vaccine, quadrivalent (ccIIV4), is indicated for the prevention of influenza disease in individuals who are at risk of contracting the virus. The following conditions and situations warrant the administration of this vaccine:
The administration of the quadrivalent influenza virus vaccine (ccIIV4) involves several key procedural steps to ensure proper delivery and effectiveness of the vaccine:
Following the administration of the quadrivalent influenza virus vaccine, patients are typically advised to remain in the healthcare setting for a brief observation period to monitor for any immediate allergic reactions. Common post-procedure care includes advising patients to apply a cool compress to the injection site if they experience soreness or swelling. Patients should also be informed about potential mild side effects, such as low-grade fever, fatigue, or localized pain at the injection site, which usually resolve within a few days. It is important for patients to understand the significance of receiving the vaccine annually, as influenza viruses can change from year to year, necessitating updated vaccinations for optimal protection.
| Short Descr | CCIIV4 VAC NO PRSV 0.5 ML IM | Medium Descr | CCIIV4 VACCINE PRESERVATIVE FREE 0.5 ML IM USE | Long Descr | Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use | Related Drugs | Flucelvax Quadrivalent | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Influenza, Pneumococcal Pneumonia, Hepatitis B, and Covid-19 Vaccines; Monoclonal Antibody Therapy Product | ASC Payment Indicator | Influenza vaccine; pneumococcal vaccine. | Berenson-Eggers TOS (BETOS) | O1G - Immunizations/Vaccinations | MUE | 1 |
| 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | GA | Waiver of liability statement issued as required by payer policy, individual case | GW | Service not related to the hospice patient's terminal condition | JZ | Zero drug amount discarded/not administered to any patient | GV | Attending physician not employed or paid under arrangement by the patient's hospice provider | GC | This service has been performed in part by a resident under the direction of a teaching physician | XS | Separate structure, a service that is distinct because it was performed on a separate organ/structure | AQ | Physician providing a service in an unlisted health professional shortage area (hpsa) | Q1 | Routine clinical service provided in a clinical research study that is in an approved clinical research study | LT | Left side (used to identify procedures performed on the left side of the body) | SA | Nurse practitioner rendering service in collaboration with a physician | 95 | Synchronous telemedicine service rendered via a real-time interactive audio and video telecommunications system: synchronous telemedicine service is defined as a real-time interaction between a physician or other qualified health care professional and a patient who is located at a distant site from the physician or other qualified health care professional. the totality of the communication of information exchanged between the physician or other qualified health care professional and the patient during the course of the synchronous telemedicine service must be of an amount and nature that would be sufficient to meet the key components and/or requirements of the same service when rendered via a face-to-face interaction. modifier 95 may only be appended to the services listed in appendix p. appendix p is the list of cpt codes for services that are typically performed face-to-face, but may be rendered via a real-time (synchronous) interactive audio and video telecommunications system. | CC | Procedure code change (use 'cc' when the procedure code submitted was changed either for administrative reasons or because an incorrect code was filed) | CG | Policy criteria applied | CS | Cost-sharing waived for specified covid-19 testing-related services that result in and order for or administration of a covid-19 test and/or used for cost-sharing waived preventive services furnished via telehealth in rural health clinics and federally qualified health centers during the covid-19 public health emergency | GT | Via interactive audio and video telecommunication systems | GY | Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit | GZ | Item or service expected to be denied as not reasonable and necessary | HA | Child/adolescent program | MA | Ordering professional is not required to consult a clinical decision support mechanism due to service being rendered to a patient with a suspected or confirmed emergency medical condition | Q5 | Service furnished under a reciprocal billing arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area | Q6 | Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area | RT | Right side (used to identify procedures performed on the right side of the body) | SL | State supplied vaccine | TB | Drug or biological acquired with 340b drug pricing program discount, reported for informational purposes | U1 | Medicaid level of care 1, as defined by each state | X1 | Continuous/broad services: for reporting services by clinicians, who provide the principal care for a patient, with no planned endpoint of the relationship; services in this category represent comprehensive care, dealing with the entire scope of patient problems, either directly or in a care coordination role; reporting clinician service examples include, but are not limited to: primary care, and clinicians providing comprehensive care to patients in addition to specialty care | X3 | Episodic/broad services: for reporting services by clinicians who have broad responsibility for the comprehensive needs of the patient that is limited to a defined period and circumstance such as a hospitalization; reporting clinician service examples include but are not limited to the hospitalist's services rendered providing comprehensive and general care to a patient while admitted to the hospital | XE | Separate encounter, a service that is distinct because it occurred during a separate encounter | XU | Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2017-01-01 | Added | Added |
Get instant expert-level medical coding assistance.